Page 1275 - Advanced Organic Chemistry Part B - Reactions & Synthesis
P. 1275

have subsequently been improved and a particularly effective coupling reagent is  1251
              1-mesitylenesulfonyl-3-nitrotriazole (MSNT). 54
                                                                                            SECTION 13.3
                                                              DMTOCH 2        B 1       Solid Phase Synthesis
                                                                          O
               DMTOCH 2        B 1  DMTOCH 2     B 1
                          O                  O                       O  P  OAr
                                 MSNT
                     O  P  OAr          O  P  OAr  HOCH 2   O    B 2    OCH 2  O  B 2
                        O –                OSO 2 Mes
                                                       O  P  OAr       O  P  OAr
                              Mes = 2,4,6-trimethylphenyl
                                                          OR              OR

                  Current solid phase synthesis of oligonucleotides relies on coupling at the
              phosphite oxidation level. The individual nucleotides are introduced as phospho-
              ramidites and the technique is called the phosphoramidite method. 55  The N,N-
              diisopropyl phosphoramidites are usually used. The third phosphorus substituent is
              methoxy or 2-cyanoethoxy. The cyanoethyl group is easily removed by mild base
              ( -elimination) after completion of the synthesis. The coupling is accomplished by
              tetrazole, which displaces the amine substituent to form a reactive phosphite that
              undergoes coupling. After coupling, the phosphorus is oxidized to the phosphoryl
              level by iodine or another oxidant. The most commonly used protecting group for the
              5 -OH is the 4,4 -dimethoxytrityl group (DMT), which is removed by mild acid. The


              typical cycle of deprotection, coupling, and oxidation is outlined in Scheme 13.79. One
              feature of oligonucleotide synthesis is the use of a capping step, an acetylation that
              follows coupling, the purpose of which is to permanently block any 5 -OH groups that

              were not successfully coupled. This prevents the addition of a nucleotide at the site in
              the succeeding cycle, terminates the further growth of this particular oligonucleotide,
              and avoids the synthesis of oligonucleotides with single-base deletions. The capped
              oligomers are removed in the final purification.
                  Silica or porous glass is usually used as the solid phase in oligonucleotide
              synthesis. The support is functionalized through an amino group attached to the
              silica surface. There is a secondary linkage through a succinate ester to the terminal

              3 -OH group.
                                                   XO   O    B 1
                                     OR       O
                                   O Si(CH 2 ) 5 NHCCH 2 CH 2 CO
                                   Si OR             O

              Although use of automated oligonucleotide synthesis is widespread, work continues on
              the optimization of protecting groups, coupling conditions, and deprotection methods,
              as well as on the automated devices. 56

              54   J. B. Chattapadyaya and C. B. Reese, Tetrahedron Lett., 20, 5059 (1979).
              55   R. L. Letsinger and W. B. Lunsford, J. Am. Chem. Soc., 98, 3655 (1976); S. L. Beaucage and
                 M. H. Caruthers, Tetrahedron Lett., 22, 1859 (1981); M. H. Caruthers, J. Chem. Ed., 66, 577 (1989);
                 S. L. Beaucage and R. P. Iyer, Tetrahedron, 48, 2223 (1992).
              56
                 G. A. Urbina, G. Grubler, A. Weiber, H. Echner, S. Stoeva, J. Schernthaner, W. Gross, and W. Voelter,
                 Z. Naturforsch., B53, 1051 (1998); S. Rayner, S. Brignac, R. Bumeiester, Y. Belosludtsev, T. Ward,
                 O. Grant, K. O’Brien, G. A. Evans, and H. R. Garner, Genome Res., 8, 741 (1998).
   1270   1271   1272   1273   1274   1275   1276   1277   1278   1279   1280